Search results
Does Anavex Life Sciences (AVXL) Have the Potential to Rally 401.47% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 5 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 401.5% in...
Anavex (AVXL): Strong Industry, Solid Earnings Estimate Revisions
Zacks via Yahoo Finance· 5 months agoOne stock that might be an intriguing choice for investors right now is Anavex Life Sciences Corp....
Anavex (AVXL) Up 12% on Regulatory Update for Alzheimer's Drug
Zacks via Yahoo Finance· 6 months agoAnavex (AVXL) announces an encouraging regulatory update for its investigational candidate,...
Anavex Life Sciences (AVXL) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 2 weeks agoAnavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
Anavex Life Sciences Corp. (NASDAQ:AVXL) Is Expected To Breakeven In The Near Future
Simply Wall St. via Yahoo Finance· 8 months agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
Zacks via Yahoo Finance· 5 months agoAnavex (AVXL) falls 35% on mixed results from the mid to late-stage study of 30 mg ANAVEX2-73 for...
Is Anavex Life Sciences Stock a Buy Now?
Motley Fool· 1 year agoAnavex Life Sciences (NASDAQ: AVXL) is a small-cap stock with big ambitions. It has a potential Alzheimer's treatment that fared well in recent trials...
Anavex's (AVXL) Lead Alzheimer's Drug Meets Study Goal
Zacks via Yahoo Finance· 1 year agoTop-line data from a phase IIb/III study shows that Anave's (AVXL) lead drug exhibited statistical...
Is Anavex Life Sciences a Buy?
Motley Fool· 1 year agoAs a pre-revenue biotech company that's approaching decisive clinical and regulatory milestones, Anavex Life Sciences (NASDAQ: AVXL) isn't an investment...